Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
Ivan Foeldvari, Jens Klotsche, Kathryn S Torok, et al.
The New England Journal of Medicine
|
August 22, 2008
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J Lovell, Nicolino Ruperto, Steven Goodman, et al.
Pediatric Rheumatology Online Journal
|
February 13, 2020
Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
Ivan Foeldvari, Jens Klotsche, Gabriele Simonini, et al.
Arthritis Research & Therapy
|
December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries
Joost Swart, Gabriella Giancane, Gerd Horneff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema
Robert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
Autoimmunity Reviews
|
January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
Vanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
JAMA
|
April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial
Dirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Journal of Scleroderma and Related Disorders
|
September 25, 2023
Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis
Jens Klotsche, Kathryn S Torok, Ozgur Kasapcopur, et al.
Pediatric Rheumatology Online Journal
|
June 4, 2014
Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis)
Marek Bohm, Maria Isabel Gonzalez Fernandez, Seza Ozen, et al.
Arthritis and Rheumatism
|
January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study
Nicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
Ivan Foeldvari, Jens Klotsche, Kathryn S Torok, et al.
The New England Journal of Medicine
|
August 22, 2008
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J Lovell, Nicolino Ruperto, Steven Goodman, et al.
Pediatric Rheumatology Online Journal
|
February 13, 2020
Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
Ivan Foeldvari, Jens Klotsche, Gabriele Simonini, et al.
Arthritis Research & Therapy
|
December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries
Joost Swart, Gabriella Giancane, Gerd Horneff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema
Robert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
Autoimmunity Reviews
|
January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
Vanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
JAMA
|
April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial
Dirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Journal of Scleroderma and Related Disorders
|
September 25, 2023
Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis
Jens Klotsche, Kathryn S Torok, Ozgur Kasapcopur, et al.
Pediatric Rheumatology Online Journal
|
June 4, 2014
Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis)
Marek Bohm, Maria Isabel Gonzalez Fernandez, Seza Ozen, et al.
Arthritis and Rheumatism
|
January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study
Nicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
Page
of 18